PHVS
Pharvaris NV
NASDAQ · Healthcare · Biotechnology · NL
$33.53
−0.15%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-57.0%
Return on equity
-52.2%
Return on assets
-60.7%
Return on invested capital
0.00x
Asset turnover
-$174.4M
Cash from operations
$5.07
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026